Literature DB >> 10607394

A locus and mechanism of action for associative morphine tolerance.

J M Mitchell1, A I Basbaum, H L Fields.   

Abstract

Repeated administration of an opioid in the presence of specific environmental cues can induce tolerance specific to that setting (associative tolerance). Prolonged or repeated administration of an opioid without consistent contextual pairing yields non-associative tolerance. Here we demonstrate that cholecystokinin acting at the cholecystokinin-B receptor is required for associative but not non-associative morphine tolerance. Morphine given in the morphine-associated context increased Fos-like immunoreactivity in the lateral amygdala and hippocampal area CA1. Microinjection of the cholecystokinin B antagonist L-365,260 into the amygdala blocked associative tolerance. These results indicate that cholecystokinin acting in the amygdala is necessary for associative tolerance to morphine's analgesic effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607394      PMCID: PMC4327857          DOI: 10.1038/71120

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  44 in total

Review 1.  Addictive drugs as reinforcers: multiple partial actions on memory systems.

Authors:  N M White
Journal:  Addiction       Date:  1996-07       Impact factor: 6.526

2.  Differential interactions of cholecystokinin and FLFQPQRF-NH2 with mu and delta opioid antinociception in the rat spinal cord.

Authors:  D S Magnuson; A F Sullivan; G Simonnet; B P Roques; A H Dickenson
Journal:  Neuropeptides       Date:  1990-08       Impact factor: 3.286

3.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

Authors:  M Lemaire; G A Böhme; O Piot; B P Roques; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

5.  Heroin "overdose" death: contribution of drug-associated environmental cues.

Authors:  S Siegel; R E Hinson; M D Krank; J McCully
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

6.  Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.

Authors:  O Valverde; R Maldonado; M C Fournie-Zaluski; B P Roques
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

7.  Proglumide prevents and curtails acute tolerance to morphine in rats.

Authors:  J Tang; J Chou; M Iadarola; H Y Yang; E Costa
Journal:  Neuropharmacology       Date:  1984-06       Impact factor: 5.250

8.  Cholecystokinin gene expression in rat amygdaloid neurons: normal distribution and effect of morphine tolerance.

Authors:  S Pu; H Zhuang; Z Lu; X Wu; J Han
Journal:  Brain Res Mol Brain Res       Date:  1994-02

9.  Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.

Authors:  A E Panerai; L C Rovati; E Cocco; P Sacerdote; P Mantegazza
Journal:  Brain Res       Date:  1987-04-28       Impact factor: 3.252

10.  Asymmetry in behavioral responses to cholecystokinin microinjected into rat nucleus accumbens and amygdala.

Authors:  I Belcheva; S Belcheva; V V Petkov; V D Petkov
Journal:  Neuropharmacology       Date:  1994-08       Impact factor: 5.250

View more
  10 in total

1.  Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.

Authors:  H Ueda; M Inoue; H Takeshima; Y Iwasawa
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.

Authors:  Lori N Eidson; Anne Z Murphy
Journal:  Peptides       Date:  2019-03-16       Impact factor: 3.750

3.  Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.

Authors:  Ana Vicente-Sanchez; Isaac J Dripps; Alycia F Tipton; Heba Akbari; Areeb Akbari; Emily M Jutkiewicz; Amynah A Pradhan
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

4.  G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.

Authors:  Gregory W Terman; Wenzhen Jin; Young-Pyo Cheong; Janet Lowe; Marc G Caron; Robert J Lefkowitz; Charles Chavkin
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

5.  Stress enables synaptic depression in CA1 synapses by acute and chronic morphine: possible mechanisms for corticosterone on opiate addiction.

Authors:  Ya Yang; Xigeng Zheng; Yongfu Wang; Jun Cao; Zhifang Dong; Jingxia Cai; Nan Sui; Lin Xu
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 6.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

Review 7.  Classical conditioning and pain: conditioned analgesia and hyperalgesia.

Authors:  Gonzalo Miguez; Mario A Laborda; Ralph R Miller
Journal:  Acta Psychol (Amst)       Date:  2013-11-22

Review 8.  Tolerance and withdrawal from prolonged opioid use in critically ill children.

Authors:  Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

9.  Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.

Authors:  C P Bailey; J Llorente; B H Gabra; F L Smith; W L Dewey; E Kelly; G Henderson
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

10.  MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1.

Authors:  Jenica D Tapocik; Kristin Ceniccola; Cheryl L Mayo; Melanie L Schwandt; Matthew Solomon; Bi-Dar Wang; Truong V Luu; Jacqueline Olender; Thomas Harrigan; Thomas M Maynard; Greg I Elmer; Norman H Lee
Journal:  Front Mol Neurosci       Date:  2016-03-24       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.